Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000315066-25-002303·Amylyx Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
Amylyx Pharmaceuticals Inc
COMMON STOCK · CUSIP: 03237H101
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- FMR LLC
Shares: 11,379,207.00 · Class: 10.7%
- Abigail P. Johnson
Shares: 11,379,207.00 · Class: 10.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-25-002303
- Form type
- SCHEDULE 13G
- Filer
- Amylyx Pharmaceuticals, Inc.
- CIK
- CIK 1658551
- Filed
- Oct 07, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership